Ignite Creation Date:
2025-12-24 @ 1:48 PM
Ignite Modification Date:
2025-12-31 @ 2:04 AM
Study NCT ID:
NCT07064395
Status:
RECRUITING
Last Update Posted:
2025-07-14
First Post:
2025-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bright Light Therapy on Sleep Health in Lung Cancer Patients
Sponsor:
Henry Ford Health System
Organization:
Study Overview
Official Title:
Bright Light Therapy to Reduce Sleep Disturbance and Biological Aging in Lung Cancer Patients
Status:
RECRUITING
Status Verified Date:
2025-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BLT
Brief Summary:
The goal of this randomized intervention trial is to determine the effect of bright light therapy on sleep disturbance, as well as to investigate the impacts of bright light therapy on biological age measured by clinical biomarkers. The main questions it aims to answer are:
* Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients?
* Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging.
Participants will:
* Receive bright light exposure or usual light exposure every day for 4 weeks
* Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests
* Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks
* Keep a daily sleep log
* Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients?
* Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging.
Participants will:
* Receive bright light exposure or usual light exposure every day for 4 weeks
* Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests
* Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks
* Keep a daily sleep log
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| F80046 | OTHER_GRANT | Henry Ford Health + Michigan State University Pilot Award | View |